Wuhan Keqian Biology Co.,Ltd

688526

CNE1000042Q8

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-23 pm EDT			5-day change	1st Jan Change
17.76 ^CNY	+1.14%		+6.60%	-12.86%

Apr. 02	Tranche Update on Wuhan Keqian Biology Co.,Ltd's Equity Buyback Plan announced on February 22, 2024.	CI
Feb. 26	Wuhan Keqian Biology Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Wuhan Keqian Biology Co.,Ltd announces decision of Shareholder/Board on the transaction

November 17, 2022

On November 18, 2022, the transaction has been approved by the shareholder of the company at its 1st Extraordinary Shareholders Meeting of 2022.

Latest news about Wuhan Keqian Biology Co.,Ltd

Tranche Update on Wuhan Keqian Biology Co.,Ltd's Equity Buyback Plan announced on February 22, 2024.	Apr. 01	CI
Wuhan Keqian Biology Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 26	CI
Wuhan Keqian Biology Co.,Ltd announces an Equity Buyback for CNY 50 million worth of its shares.	Feb. 21	CI
Wuhan Keqian Biology Co.,Ltd authorizes a Buyback Plan.	Feb. 19	CI
Wuhan Keqian Biology Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
Certain A Shares of Wuhan Keqian Biology Co.,Ltd are subject to a Lock-Up Agreement Ending on 22-SEP-2023.	23-09-21	CI
Wuhan Keqian Biology Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28	CI
Wuhan Keqian Biology Elects Chairman, Vice Chairman	23-07-06	MT
Wuhan Keqian Biology Co.,Ltd cancelled the transaction announced on October 28, 2022	23-06-25	CI
Wuhan Keqian Biology Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-17	CI
Wuhan Keqian Biology Co.,Ltd announces decision of Shareholder/Board on the transaction	22-11-17	CI
Wuhan Keqian Biology’s New Swine Vaccines Obtain Registration Certificates in China	22-11-10	MT
Wuhan Keqian Biology Partners With University for Vaccine Development	22-11-03	MT
Wuhan Keqian Biology Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-28	CI
Wuhan Keqian Biology Co.,Ltd announced a financing transaction	22-10-27	CI
Certain A Shares of Wuhan Keqian Biology Co.,Ltd are subject to a Lock-Up Agreement Ending on 22-SEP-2022.	22-09-21	CI
Wuhan Keqian Biology Co.,Ltd(XSSC:688526) added to S&P Global BMI Index	22-09-19	CI
Wuhan Keqian Biology Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-29	CI
Wuhan Keqian Biology Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-18	CI
Wuhan Keqian Biology Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-25	CI
China shares fall on tech weakness; China Mobile edges higher in Shanghai debut	22-01-05	RE
Wuhan Keqian Biology Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-27	CI
Certain A Shares of Wuhan Keqian Biology Co.,Ltd are subject to a Lock-Up Agreement Ending on 22-SEP-2021.	21-09-21	CI
Wuhan Keqian Biology Co.,Ltd(SHSE:688526) added to Shanghai Stock Exchange Composite Index	21-09-20	CI
Wuhan Keqian Biology Co.,Ltd(SHSE:688526) added to Shanghai Stock Exchange A Share Index	21-09-20	CI

Chart Wuhan Keqian Biology Co.,Ltd

Duration

Period

More charts

Wuhan Keqian Biology Co Ltd is a China-based company mainly engaged in the research and development, production, sales of veterinary biological products and the provision of animal epidemic prevention technical services. The Company's main products are vaccines for swine and poultry. The Company mainly conducts its businesses within the China market.

Sector

Pharmaceuticals

Calendar

2024-08-26 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Wuhan Keqian Biology Co.,Ltd

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

17.56 CNY

Average target price

24.75 CNY

Spread / Average Target

+40.95%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Veterinary Drugs

	1st Jan change	Capi.
WUHAN KEQIAN BIOLOGY CO.,LTD	-12.86%	1.13B
ELANCO ANIMAL HEALTH INCORPORATED	-8.89%	6.64B
BLUESTAR ADISSEO COMPANY	+16.00%	3.41B
VIRBAC	+0.42%	3.21B
VIMIAN GROUP AB	+3.04%	1.46B
JINYU BIO-TECHNOLOGY CO., LTD.	-14.67%	1.38B
VETOQUINOL SA	-2.44%	1.25B
CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.	-27.57%	1.21B
TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD.	-1.95%	1.03B
SWEDENCARE AB	-6.99%	843M

Veterinary Drugs